These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10502041)

  • 41. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
    Ben-Hur H; Mordechay E; Halperin R; Gurevich P; Zandbank J; Herper M; Zusman I
    Oncol Rep; 2002; 9(5):977-80. PubMed ID: 12168058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
    Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
    Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
    Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
    J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H
    J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
    Küenzi P; Schneider P; Dobbelaere DA
    J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
    Riffkin CD; Gray AZ; Hawkins CJ; Chow CW; Ashley DM
    Neuro Oncol; 2001 Oct; 3(4):229-40. PubMed ID: 11584892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma.
    Fujieda S; Sunaga H; Tsuzuki H; Fan GK; Ito T; Sugimoto C; Saito H
    Cancer Lett; 2000 Dec; 161(1):73-81. PubMed ID: 11078915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of Fas ligand and bcl-2 in cervical carcinoma and their prognostic significance.
    Munakata S; Watanabe O; Ohashi K; Morino H
    Am J Clin Pathol; 2005 Jun; 123(6):879-85. PubMed ID: 15899779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presence of Fas-Fas ligand system and bcl-2 gene products in cells and fluids from gonadotropin-stimulated human ovaries.
    José de los Santos M; Anderson DJ; Racowsky C; Hill JA
    Biol Reprod; 2000 Dec; 63(6):1811-6. PubMed ID: 11090453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells.
    Frassanito MA; Silvestris F; Silvestris N; Cafforio P; Camarda G; Iodice G; Dammacco F
    Clin Exp Immunol; 1998 Nov; 114(2):179-88. PubMed ID: 9822274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
    Saas P; Walker PR; Hahne M; Quiquerez AL; Schnuriger V; Perrin G; French L; Van Meir EG; de Tribolet N; Tschopp J; Dietrich PY
    J Clin Invest; 1997 Mar; 99(6):1173-8. PubMed ID: 9077524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
    Mitsiades N; Poulaki V; Kotoula V; Mastorakos G; Tseleni-Balafouta S; Koutras DA; Tsokos M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2199-203. PubMed ID: 9626160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis of bovine granulosa cells after serum withdrawal is mediated by Fas antigen (CD95) and Fas ligand.
    Hu CL; Cowan RG; Harman RM; Porter DA; Quirk SM
    Biol Reprod; 2001 Feb; 64(2):518-26. PubMed ID: 11159354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. alpha(v)beta(3) Integrin in central nervous system tumors.
    Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
    Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Fas and Fas ligand in Hodgkin's disease.
    Metkar SS; Naresh KN; Redkar AA; Soman CS; Advani SH; Nadkarni JJ
    Leuk Lymphoma; 1999 May; 33(5-6):521-30. PubMed ID: 10342579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
    Ravandi F; Kantarjian HM; Talpaz M; O'Brien S; Faderl S; Giles FJ; Thomas D; Cortes J; Andreeff M; Estrov Z; Rios MB; Albitar M
    Cancer; 2001 Jun; 91(11):1964-72. PubMed ID: 11391574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
    Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
    Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.